Clinical Trial Update: Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a gene therapy for Hemophilia B in patients aged 12-18 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia B | Phase 1 | Status: RECRUITING